Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hangying Li has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The hepatoprotective effect of Lycium barbarum glycopeptide on immunological liver injury in mice

    by Qiying Shen, Mingxing Ye, Jiexin Wang, Qian Liu, Rui Wu, Zhexiong Yu, Yun Ji, Hangying Li, Liming Zhang


  • Open Access

    Bibliometric Mapping of Quercetin Research: Analysis of the Most‐Cited Articles (2000–2023)

    by Aijuan Yang, Jiyun Wang, Wei Yang, Zhengfei Yang, Liming Zhang, Hangying Li

    Quercetin, a naturally occurring flavonoid with demonstrated antioxidant, anti‐inflammatory, and anticancer properties, has emerged as a focal point in biomedical research. Despite extensive studies, a systematic bibliometric analysis of quercetin research remains lacking. To visualize research trends, collaboration networks, and knowledge domains of quercetin research, we analyzed the top 200 most‐cited articles from the Web of Science Core Collection (2000–2023) using VOSviewer software to visualize research trends, collaboration networks, and knowledge domains. The analysis identified China ( n = 44; 11,238 citations) and the United States ( n = 33; 8254 citations) as the leading contributors, with Tokushima University emerging as the most productive institution ( n = 6; 1800 citations). The most influential research team was the Wolffram, Siegfried, and Hollman, PCH group. The Journal of Agricultural and Food Chemistry emerged as the top publishing journal ( n = 14; 3738 citations). Science mapping through keyword co‐occurrence analysis identified four primary research hotspots: (1) molecular mechanisms and delivery systems, (2) therapeutic applications, (3) active constituents and analytical methods, and (4) metabolic and cellular regulation. Major research topics included cancer ( n = 31; 7271 citations), antioxidant effects ( n = 20; 6513 citations), and neurological diseases ( n = 17; 3544 citations). The dominant research areas were biochemistry and molecular biology ( n = 40; 9997 citations) and pharmacology and pharmacy ( n = 39; 11,208 citations). The study maps the field's intellectual structure, collaboration dynamics, and developmental trajectories, providing clear identification of knowledge gaps and strategic direction for future research in this rapidly evolving field.


  • Open Access

    Total Alkaloid Extract of Nelumbinis Plumula Promoted Sleep in PCPA-Induced Insomnia Rats by Affecting Neurotransmitters and Their Receptor Activities

    by Wenjun Wei, Dongge Wang, Hangying Li, Hongyu Tian, Zhilei Wang, Suxiang Feng

    Insomnia seriously affects people’s health and daily life. There is a growing interest in sleep-promoting agents from natural sources. Nelumbinis Plumula (NP), a traditional Chinese medicine with dual food-medicine homology, has the effects of clearing the heart and calming the mind, showing promising efficacy in treating insomnia. In this study, the effects of NP extract, total alkaloid extract of NP, and crude polysaccharide of NP were measured in para-chlorophenylalanine-induced insomnia rats combined with the pentobarbital sodium experiment. The results indicated both total alkaloid extract and NP total extract could improve insomnia in rats, with the total alkaloid extract demonstrating a stronger effect than NP total extract. Total alkaloid extract significantly prolonged sleep duration and shortened sleep latency. Therefore, total alkaloids in NP appeared to be the main pharmacological substances that exerted sedative effect. Simultaneously, total alkaloid extract could increase the GABA level and reduce the DA level as well as affect the activities of GABRA1, DRD2, 5-HT1A, and AChE proteins. This study can lay an experimental foundation for the further development and application of NP as a remedy for treating insomnia.


  • Open Access

    Research Progress of Natural Active Substances with Immunosuppressive Activity

    by Fei Shao, Qiying Shen, Zhengfei Yang, Wenqian Yang, Zixiang Lu, Jie Zheng, Liming Zhang, Hangying Li

    The increasing prevalence of autoimmune diseases globally has prompted extensive research and the development of immunosuppressants. Currently, immunosuppressive drugs such as cyclosporine, rapamycin, and tacrolimus have been utilized in clinical practice. However, long-term use of these drugs may lead to a series of adverse effects. Therefore, there is an urgent need to explore novel drug candidates for treating autoimmune diseases. This review aims to find potential candidate molecules for natural immunosuppressive compounds derived from plants, animals, and fungi over the past decade. These compounds include terpenoids, alkaloids, phenolic compounds, flavonoids, and others. Among them, compounds 49, 151, 173, 200, 204, and 247 have excellent activity; their IC50 were less than 1 μM. A total of 109 compounds have good immunosuppressive activity, with IC50 ranging from 1 to 10 μM. These active compounds have high medicinal potential. The names, sources, structures, immunosuppressive activity, and the structure-activity relationship were summarized and analyzed.


  • Open Access

    Ethyl Acetate Extract from Artemisia argyi Prevents Liver Damage in ConA-Induced Immunological Liver Injury Mice via Bax/Bcl-2 and TLR4/MyD88/NF-κB Signaling Pathways

    by Wenqian Yang, Fei Shao, Jiexin Wang, Tong Shen, Yu Zhao, Xueyan Fu, Liming Zhang, Hangying Li

    Background: Immunological liver injury (ILI) is a common liver disease and lacks potent drugs for treatment. Artemisia argyi Lévl. et Vant. (A. argyi), a medicinal and edible homologous plant usually used in diet therapy to cure various liver diseases, provides a great option for the prevention of ILI. Purpose: To investigate the effect that ethyl acetate extract of A. argyi (AaEA) on Concanavalin A (ConA)-induced ILI and the mechanism of regulating Bax/Bcl-2 and TLR4/MyD88/NF-κB signaling pathways. Methods: The chemical components of AaEA were studied by LC-MS. In animal experiments, the positive control group was administrated diammonium glycyrrhizinate (DIG, 100 mg/kg), while different doses of AaEA groups (AaEA-H, AaEA-M, AaEA-L) were pretreated with AaEA 2.00, 1.00, and 0.50 g/kg, respectively, by intragastric for seven days, once every day. Then, ConA (12.00 mg/kg) was used through tail intravenous injection to establish the ILI model. The blood samples and livers were collected to test the degree of liver dysfunction, inflammation, oxidative stress, histopathological changes, and cell apoptosis. Real-time PCR and Western blotting analysis were used to explain the mechanism of regulating Bax/Bcl-2 and TLR4/MyD88/NF-κB signaling pathways. Results: The way in which AaEA prevents liver damage in immunological liver injury (ILI) mice caused by ConA was investigated for the first time. Pretreatment with AaEA reduced the expression of ALT, AST, and inflammatory factors (TNF-α and IFN-γ). Meanwhile, AaEA also reduced MDA levels but upregulated the contents of IL-4, SOD, and GSH-px, alleviating oxidative stress induced by ILI. Western blotting and real-time PCR analysis demonstrated that AaEA could regulate the expression level and relative mRNA expression of key proteins on Bax/Bcl-2 and TLR4/MyD88/NF-κB signaling pathways. Finally, 504 components from AaEA were identified by LC-MS analysis, mainly including flavones, phenolic acids, and terpenoids with anti-inflammatory and liver protective activities, which highlights the potential of AaEA for diet treatment of ILI. Conclusion: AaEA can work against ConA-induced ILI in mice by regulating Bax/Bcl-2 and TLR4/MyD88/NF-κB signaling pathways, which has the potential to be a great strategy for the prevention of ILI.


  • Open Access

    A Network Pharmacology Approach to Investigate the Mechanism of Erjing Prescription in Type 2 Diabetes

    by Jiexin Wang, Haiqing Chu, Hangying Li, Wenqian Yang, Yu Zhao, Tong Shen, John Cary, Liming Zhang

    Erjing prescription (EJP) was an ancient formula that was recorded in the General Medical Collection of Royal Benevolence of the Song Dynasty. It has been frequently used to treat type 2 diabetes mellitus (T2DM) in the long history of China. The formula consists of Lycium barbarum L. and Polygonatum sibiricum F. Delaroche with a ratio of 1:1. This study aimed to identify the potential effects and mechanisms of EJP treatment T2DM. The target proteins and possible pathways of EJP in T2DM treatment were investigated by the approach of network pharmacology and real-time PCR (RT-PCR). 99 diabetes-related proteins were regulated by 56 bioactive constituents in EJP in 26 signal pathways by Cytoscape determination. According to GO analysis, 606 genes entries have been enriched. The PPI network suggested that AKT1, EGF, EGFR, MAPK1, and GSK3β proteins were core genes. Among the 26 signal pathways, the PI3K-AKT signal pathway was tested by the RT-PCR. The expression level of PI3K p85, AKT1, GSK3β, and Myc mRNA of this pathway was regulated by EJP. The study based on network pharmacology and RT-PCR analysis revealed that the blood sugar level was regulated by EJP via regulating the PI3K-AKT signal pathway. Plenty of new treatment methods for T2DM using EJP were provided by network pharmacology analysis.